drugset / Trial / NCT03390374

Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants

NCT03390374

Phase 4 Completed 95 enrolled Dr Cipto Mangunkusumo General Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

This study determines the effectiveness of oral nystatin as prophylaxis in order to prevent systemic fungal infection in very low birth weight preterm neonates. 47 participants received oral nystatin and 48 participants received sterile water as part of oral hygiene.

Timeline

Start
2010-10
Primary completion
2012-11
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nystatin Unknown 1 ml Oral

Indications